Basis: (FMP quote price / unrounded diluted TTM EPS) / five-year diluted EPS CAGR in percent, from annual statements through the period end shown. Source: stored company filings and market data; unavailable inputs remain N/A.
The PEG ratio is N/A as of 2026-10-06T18:58:53.639Z.
Calculation as of: 2026-10-06T18:58:53.639Z.
Quote observation: 2026-10-06T17:25:57.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 0fde8dae4c5ae63ee7b35c7e6e46bba2fdf5d6d5db310b32cf0eb41a7e17e840
PEG RATIO
N/A
Thunder Bridge Capital Partners V L
Market Cap
$266.29M
PEG Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$266.99M
PEG Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$264.38M
PEG Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$269.65M
PEG Ratio
N/A
TTM Avg
0.21
3Y Avg
0.29
5Y Avg
0.29
| NAME | MARKET CAP | PEG RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Thunder Bridge Capital Partners V L (TBCVU) | $266.29M | N/A | N/A | N/A | N/A |
| Translational Development Acquisition Corp. (TDAC)vs › | $266.99M | N/A | N/A | N/A | N/A |
| Oaktree Acquisition Corp. II (OACC)vs › | $264.51M | N/A | N/A | N/A | N/A |
| ProCap Acquisition Corp (PCAP)vs › | $264.47M | N/A | N/A | N/A | N/A |
| Drugs Made In America Acquisition Corp. Ordinary Shares (DMAA)vs › | $264.38M | N/A | N/A | N/A | N/A |
| Hawthorn Bancshares, Inc. (HWBK)vs › | $265.12M | 0.85 | 1.72 | 1.74 | 1.04 |
| Soren Acquisition Corp. (SORN)vs › | $263.53M | N/A | N/A | N/A | N/A |
| Kingstone Companies, Inc. (KINS)vs › | $269.42M | 0.08 | 0.07 | 0.07 | 0.07 |
| Runway Growth Finance Corp. (RWAY)vs › | $269.65M | N/A | 0.21 | 0.29 | 0.29 |
| Cartesian Growth Corp. Iv (CGCF)vs › | $270.05M | N/A | N/A | N/A | N/A |
PEG Ratio
N/A
P/E Ratio
N/A
PEG Ratio = P/E Ratio / 5-Year Diluted EPS CAGR (%)
The PEG ratio divides the price-to-earnings ratio by the company's five-year compound annual growth rate of diluted EPS, expressed in percent. A P/E of 20 and a five-year diluted EPS CAGR of 10% give a PEG of 2.0. The growth is reported, historical earnings growth from annual statements, not an analyst forecast. A PEG near 1 is often read as fairly priced for its growth; lower can mean cheaper relative to growth. The ratio is N/A when the P/E is unavailable or not positive, or when the five-year diluted EPS CAGR is unavailable or not positive. Each day of the history uses the CAGR that was known on that day.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
